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Certain bacteria use cell-to-cell chemical communication to coordinate community-wide phenotypic expres-
sion, including swarming motility, antibiotic biosynthesis, and biofilm production. Here we present a marine
gram-positive bacterium that secretes secondary metabolites capable of quenching quorum sensing-controlled
behaviors in several gram-negative reporter strains. Isolate C42, a Halobacillus salinus strain obtained from a
sea grass sample, inhibits bioluminescence production by Vibrio harveyi in cocultivation experiments. With the
use of bioassay-guided fractionation, two phenethylamide metabolites were identified as the active agents. The
compounds additionally inhibit quorum sensing-regulated violacein biosynthesis by Chromobacterium viola-
ceum CV026 and green fluorescent protein production by Escherichia coli JB525. Bacterial growth was unaf-
fected at concentrations below 200 g/ml. Evidence is presented that these nontoxic metabolites may act as
antagonists of bacterial quorum sensing by competing with N-acyl homoserine lactones for receptor binding.
Taxonomically diverse marine bacteria have proven to be a
rich resource for the discovery of structurally unique and bio-
active secondary metabolites (5). Given the intense microbial
competition for resources such as space and nutrients, it is
probable that many excreted metabolites help mediate mi-
crobe-microbe interactions. Various antibiotics have been im-
plicated as chemical defenses for marine bacteria, thus sug-
gesting a role for the biosynthesis of toxic metabolites. For
example, a pelagic Alteromonas species produces the antibiotic
2-n-pentyl-4-quinolinol, capable of influencing bacterial com-
munity structure on particles (25), and production of the an-
tibiotic andrimid by a marine Vibrio species prevents coloniza-
tion of surfaces by the particle specialist Vibrio cholerae (26).
Though not yet widely studied, the secretion of nontoxic
molecules could also play important roles in antagonistic ma-
rine microbial interactions. Quorum sensing pathways of com-
peting bacteria are potential targets for such nontoxic chemical
defenses. Bacterial communication is facilitated by the produc-
tion and subsequent recognition of small signaling molecules
(autoinducers) and can regulate important phenotypes, includ-
ing bioluminescence, biofilm formation, swarming motility, an-
tibiotic biosynthesis, and virulence factor production (3, 7, 15).
Gram-negative bacteria commonly use N-acyl homoserine lac-
tones (AHL) as signaling molecules, which bind their cognate
receptor proteins to activate gene expression (10). These au-
toinducers share a conserved L-homoserine lactone moiety,
and the length and sites of oxidation on the acyl chain dictate
the species specificity (37). In contrast, gram-positive bacteria
generally accomplish quorum sensing using posttranslationally
modified peptides as autoinducers. For example, Staphylococ-
cus aureus uses cyclic oligopeptides to regulate virulence factor
production (11).
Here we report the production of nontoxic secondary me-
tabolites by a marine gram-positive bacterium that interfere
with quorum sensing-regulated phenotypes in several gram-
negative species. Using a cocultivation experiment, a marine
Halobacillus salinus isolate was discovered to inhibit biolumi-
nescence, a quorum sensing-controlled phenotype, by Vibrio
harveyi. Bioassay-guided fractionation led to the identification
of two secondary metabolites responsible for the observed
activity (Fig. 1). These compounds further quenched quorum
sensing-controlled activities in two additional reporter strains.
To our knowledge, this is the first example of secondary me-
tabolites secreted by bacilli that inhibit quorum sensing-regu-
lated behaviors in gram-negative species.
MATERIALS AND METHODS
Media. Isolation and propagation media consisted of the following: (i) Luria-
Bertani broth (LB) (4), (ii) LB containing 4 g sodium chloride (LB4), (iii)
nutrient broth (NB) containing 3 g beef extract and 5 g peptone per liter
deionized H2O, and (iv) marine broth (MB) containing 1 g yeast extract and 5 g
peptone per liter synthetic seawater (Instant Ocean; 36 g per liter). For agar
media, 15 g agar per liter of H2O was used. For soft agar media, 8 g agar per liter
of H2O was used.
Source of quorum sensing autoinducers and antagonists. N-Hexanoyl-L-ho-
moserine lactone (HHL) and N-decanoyl-DL-homoserine lactone (DHL) were
synthesized as described by Chhabra et al. (6). DHL was used as a positive
control for quorum sensing inhibition in the disc diffusion assays at 200 g per
disc (31). 4-Bromo-5-(bromomethylene)-2-(5H)-furanone was synthesized as re-
ported previously (28) and used as a positive control in broth dilution assays (1).
The 3-oxo-hexanoyl-homoserine lactone (OHHL) was purchased from Sigma-
Aldrich.
Isolation and identification of bacterial isolate C42. Bacterial strain C42 was
isolated from a sea grass sample collected in 2002 from Point Judith Salt Pond,
South Kingstown, RI. The sea grass was sectioned with a sterile scalpel, and a
portion was submerged in 1 ml of autoclaved sterile seawater, vortexed for
several seconds, and heat shocked at 70°C for 6 min. One hundred microliters of
the resulting water was spread onto an MB agar plate and incubated at ambient
temperature for several days. Isolate C42 was picked as a single colony and
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restreaked a minimum of twice to ensure a pure strain. C42 is cultivatable in MB
at 25°C. The isolate was stored in 25% glycerol at 80°C.
Phylogenetic identification of C42 was accomplished using 16S rRNA gene
sequence comparison. Total DNA was extracted using the DNeasy tissue kit
(Qiagen, Valencia, CA) per the manufacturer’s protocol. Amplification of the
bacterial 16S rRNA gene was performed with B27F forward primer (5-AGA
GTT TGA TCC TGG CTC AG-3) and B1392R reverse primer (5-ACG GGC
GGT GTG TRC-3) and an annealing temperature of 60°C. Sequencing was
conducted on an Applied Biosystems 3130xl genetic analyzer at the Rhode Island
Genomics and Sequencing Center (Kingston, RI).
Quorum sensing reporter strains and assays. V. harveyi BB120 (2), a wild-type
bioluminescent strain, was cultivated at 30°C in MB. Bioluminescence was ob-
served using a Typhoon 9410 variable mode imager (GE Healthcare Bio-Sci-
ences) in chemiluminescence mode. Chromobacterium violaceum ATCC 12472
produces the pigment violacein in response to threshold concentrations of the
autoinducer HHL (33). C. violaceum was cultured at 29°C with shaking in NB. C.
violaceum CV026 is a mini-Tn5 transposon mutant of C. violaceum ATCC 31532
that produces violacein only with exogenous addition of HHL (31). CV026 was
cultured in LB at 29°C, and disc diffusion assays were conducted with 30 M
HHL added as a supplement to the soft agar. Escherichia coli JB525 is E. coli
MT102 harboring the gfp plasmid pJBA132. This mutant produces an unstable
green fluorescent protein (GFP) in response to C6-C8 AHL autoinducers (1). E.
coli JB525 was cultured in LB4 at 30°C.
A bacterium-bacterium competition assay was used to assess the ability of
isolate C42 to inhibit bioluminescence by V. harveyi BB120. Two microliters of
overnight culture of C42 in MB was spotted onto an MB agar plate and incu-
bated at 23°C for 48 h. The colony was covered with a sterile 12,000- to 14,000-
molecular-weight-cutoff (MWCO) dialysis membrane (Spectra/Por; Spectrum
Medical Industries, Inc., Houston, TX), overlaid with 5 ml of MB soft agar
seeded with 50 l of overnight V. harveyi BB120, and incubated at 30°C for 12 to
16 h. Bioluminescence was observed using a Typhoon 9410 variable mode imager
in chemiluminescence mode. Zones of no light production were measured to the
nearest mm. The competition assay was also conducted using sterilized 3,000- to
4,000-MWCO dialysis membranes.
Disc diffusion assays were performed with pure compounds or crude mixtures
at 500 g/disc. Fifty microliters of overnight bacterial culture was added to 5 ml
of molten soft agar, vortexed, and poured atop an agar plate. Impregnated,
sterile discs were laid onto the test plates and incubated overnight. Zones of
inhibition (ZOIs; light or pigment production) were measured to the near-
est mm.
Broth assays were performed as follows with pure compounds. An over-
night culture of V. harveyi BB120 in MB was diluted (optical density at 600 nm
[OD600]  0.1), and 100 l of the diluted culture was added to 5 ml of MB
and separated into 995-l subsamples. Five microliters of test compounds
dissolved in dimethyl sulfoxide (DMSO) was added to the bacterial cultures.
The treated cultures were distributed to the wells of an opaque microtiter
plate (Nunc A/S, Denmark; 0.5 to 500 M test compound; 0.5% DMSO final
concentration) and incubated at 30°C with shaking for 4 h. The plates were
read on a Packard Lumicount microtiter plate reader (Packard, United King-
dom). Relative luminescence units were normalized by the OD600 values
obtained by transferring 100 l to a clear-bottomed microtiter plate (Spec-
traMax Multimode Microplate Reader; Molecular Devices). Percent lumi-
nescence was calculated by defining the untreated cells (no inhibitor) as
100%.
Inhibition of fluorescence was determined using a method modified from the
work of Andersen et al. (1). An overnight culture of E. coli JB525 in LB4 broth
was diluted to an OD450 of 0.25 with fresh medium and treated with the test
compounds and OHHL, each dissolved in DMSO (32 nM OHHL; 0.01 to 1,000
M test compound; 0.8% DMSO final concentration). Two hundred microliters
of the final culture was added to wells of an opaque microtiter plate and incu-
bated with shaking at 30°C for 90 min. Fluorescence was determined using a
Packard Fluorocount microtiter plate reader (  480-nm excitation,  
515-nm emission). Relative fluorescence values were normalized by optical den-
sity values obtained by transferring 100 l to a clear-bottomed microtiter plate
(  450 nm; SpectraMax Multimode Microplate Reader). The assay was also
performed with increasing serial concentrations of OHHL (16 nM to 512 nM).
Percent fluorescence was calculated by defining the cells with no inhibitor
present as 100% for each autoinducer concentration.
Mathematical modeling of the data. To characterize the pharmacodynamic
relationship between compound 2 and OHHL, the data were fitted into the
equations below. Equation 1 represents the concentration-effect relationship for
two compounds working competitively on the same receptor, and equation 2
represents the composite effect of the two compounds working on different
receptors (22). The data were fitted using nonlinear regression analysis imple-
mented in SPSS version 16.0 statistical software (SPSS Inc., Chicago, IL).
Effect E0 Emax1  
C1
EC501
n1 Emax2   C2EC502
n2
1  C1EC501
n1
  C2EC502
n2  (1)
Effect E0  Emax1  C1n1EC501n1  Cn1   Emax2  C2
n2
EC502n2  C2
n1 (2)
E0 is the baseline effect, Emax is the maximal effect, EC50 is the concentration at
half-maximal effect (50% effective concentration), n is the constant expressing
the sigmoidicity of the concentration-effect relationship, and 1 and 2 denote the
parameters estimated for antagonist and agonist, respectively.
Extraction and isolation of active compounds produced by isolate C42. Two
milliliters of H. salinus isolate C42 overnight culture in MB was spread evenly
onto agar surfaces (16-  30-cm aluminum trays; 250 ml MB agar per tray; 100
trays) and incubated at 23°C for 48 h. Whole cultures were extracted three times
with ethyl acetate (EtOAc). The resulting extracts were concentrated in vacuo
and fractionated by vacuum liquid chromatography on silica gel in 20% stepwise
gradients of EtOAc in isooctane (TMP). Bioassays conducted against V. harveyi
BB120 demonstrated activity in the 80% (448-mg) and 100% (440-mg) EtOAc
fractions. 1H nuclear magnetic resonance (NMR) spectra of these two fractions
appeared nearly identical. Reversed-phase high-pressure liquid chromatography
(X-Terra Prep RP C18 column, 100  19 mm; 10% to 60% methanol [MeOH]
in H2O at 10 ml per min; UV detection at   220 and 254 nm) of the 100%
EtOAc fraction yielded active metabolites 1 (96 mg) and 2 (123 mg). Mass
spectral data were acquired in MeOH-H2O (1:1) containing 0.1% acetic acid
(Applied Biosystems Mariner Mass Spectrometer). NMR spectra were recorded
on a Bruker Biospin spectrometer (400 MHz for 1H, 100 MHz for 13C) and
were referenced to residual solvent signals with resonances dH/C 3.31/49.15
(MeOH-d4).
Synthesis of phenethylamide metabolites. Isovaleric acid or isobutyric acid
(39.8 mmol, 1 eq) in 50 ml acetonitrile was treated with 1-ethyl-3-[3-dimethyl-
aminopropyl] carbodiimide hydrochloride (47.7 mmol, 1.2 eq), 1-hydroxybenzo-
triazole (47.7 mmol, 1.2 eq), diisopropylethylamine (59.6 mmol, 1.5 eq), and
phenethylamine (39.8 mmol, 1 eq). The reaction mixture was stirred overnight at
ambient temperature, concentrated in vacuo, and then partitioned between
EtOAc and 0.5 N HCl. The organic phase was separated, sequentially extracted
with saturated NaHCO3 and H2O, dried over Na2SO4, and evaporated to dry-
ness. Desired products were purified by silica gel column chromatography (Se-
lecto Scientific) using 30% EtOAc in TMP, followed by recrystallization from
TMP and EtOAc. Products were analyzed by NMR and mass spectrometry as
described above and were identical to the purified natural products.
Detection of lactonase genes. Amplification of the aiiA lactonase gene by PCR
was performed as described by Dong et al. (8) with the following modification.
PCR was performed using optimized conditions consisting of an initial denatur-
ation step of 5 min at 94°C, followed by 30 cycles of 30 s at 94°C, 30 s at 44.9°C,
and 1 min at 72°C and a final extension time of 7 min at 72°C. Bacillus cereus was
used as a positive control for the lactonase gene.
RESULTS
Bacterial isolate C42 was cultivated from a sea grass sample
collected from a Rhode Island estuary. Attempts to culture the
bacterium on MB agar plates prepared with fresh H2O re-
sulted in no growth, indicating that the organism is obligate
marine. A BLAST search (NCBI, 1 November 2007) of the
amplified 16S rRNA gene sequence (1,353 bases, deposited
with GenBank under accession no. EU259061) clearly placed
FIG. 1. Structures of cell signaling antagonists produced by marine
Halobacillus salinus isolate C42. Compound 1, N-(2-phenylethyl)-
isobutyramide; compound 2, 3-methyl-N-(2-phenylethyl)-butyramide.
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this isolate in the genus Halobacillus, with the nearest charac-
terized species being H. salinus strain HSL-3 (99% similarity).
Isolate C42 demonstrated the ability to inhibit biolumines-
cence of V. harveyi in a cocultivation experiment. Colonies of
C42 were cultivated on a marine agar plate for 48 h and then
covered with 12,000- to 14,000-MWCO dialysis membranes. V.
harveyi seeded in soft marine agar was poured over the mem-
brane, and the plate was incubated for 12 to 16 h. Upon
conclusion of the assay, distinct dark zones of approximately 25
mm surrounded the established 5-mm C42 bacterial colony
(Fig. 2a). No visible growth inhibition of V. harveyi was ob-
served. The assay was repeated with 3,000- to 4,000-MWCO
dialysis membranes, and the same results were recorded.
The above experiment suggested that small molecules might
be diffusing across the dialysis membrane and interfering with
luminescence by V. harveyi. Experiments were conducted to
test if secreted cell signaling antagonists were responsible for
the observed activity. A large-scale cultivation of C42 was un-
dertaken on 100 trays of marine agar for 48 h at 25°C. The
whole cultures were extracted with EtOAc, yielding 2 g of
crude extracts. Disc diffusion assays against V. harveyi BB120
demonstrated inhibition of bioluminescence without any visi-
ble effects on bacterial growth (ZOI, 63 mm; 500 g/disc).
Bioassay-guided fractionation of the active agents was accom-
plished using silica gel chromatography followed by reversed-
phase high-pressure liquid chromatography purification. These
efforts resulted in the purification of two active metabolites.
Compound 1 displayed a 15-mm ZOI and compound 2 dis-
played a 22-mm ZOI against V. harveyi BB120 in disc diffusion
assays (500 g/disc). The pure metabolites were identified as
N-(2-phenylethyl)-isobutyramide (1) and 3-methyl-N-(2-phe-
nylethyl)-butyramide (2) based on comparison of 1H and 13C
NMR and mass spectral data with literature values (30). De
novo synthesis of the identified metabolites confirmed the pre-
dicted structures and measured bioactivities (Fig. 2b and see
below) of these metabolites.
Some members of the genus Bacillus are reported to quench
quorum sensing by enzymatic degradation of the lactone sig-
naling molecules (9). Isolate C42 was analyzed for the presence
of lactonase genes; however, molecular analysis provided no
evidence for the presence of previously reported lactonase
genes. C42 did not detectably degrade autoinducers in an AHL
degradation assay (data not shown [8]). Therefore, enzymatic
degradation was not a contributing factor in the observed in-
hibition of bioluminescence by isolate C42.
Metabolites inhibit multiple quorum sensing-regulated phe-
notypes. Since bioluminescence is a quorum sensing-regulated
phenotype, the metabolites were further tested for activity
against other quorum sensing reporter strains. Disc diffusion
assays were conducted against C. violaceum CV026, a bacterial
strain that produces the purple pigment violacein in response
to threshold concentrations of exogenously supplied HHL
(31). Both compounds inhibited violacein production without
visible growth inhibition. ZOIs of 10 mm and 13 mm were
observed for compounds 1 and 2, respectively, when tested at
500 g/disc. Both compounds were additionally tested against
the wild-type strain C. violaceum ATCC 12472. This bacterium
requires no exogenous addition of autoinducer and is thus
more ecologically relevant. Compound 2 demonstrated in-
creased activity with a zone of 20 mm at 500 g/disc, while
compound 1 retained the same activity against the wild-type
strain.
The metabolites inhibited bioluminescence of planktonically
growing V. harveyi BB120. The treated cultures were grown in
microtiter plate wells in the presence of a compound or control
for 4 h, and then luminescence was measured with a Packard
Lumicount microtiter plate reader. Compound 2 inhibited
bioluminescence with an EC50 of 9 g/ml (Fig. 3). Compound
1 had no notable activity in this assay. The cultures were then
shaken for an additional 14 h, and bacterial growth was mea-
sured (OD600) to test for antibiotic activity. Neither of the two
compounds demonstrated growth inhibition at the highest con-
centrations tested (100 g/ml).
The similar molecular sizes and structures of the inhibitors
and AHL autoinducers suggested that the phenethylamides
might be AHL structural mimics and compete for receptor
binding. The mutant E. coli JB525 strain was used to test this
hypothesis. This sensor strain produces the LuxR AHL recep-
tor of Vibrio fischeri, and once activated by exogenously sup-
plied autoinducer, LuxR positively affects expression of a luxI
promoter that then initiates production of an unstable GFP
(1). Thus, AHL binding to LuxR can be measured as a function
GFP fluorescence. Since the strain can sense but not produce
FIG. 2. Inhibition of V. harveyi bioluminescence by marine Haloba-
cillus isolate C42. (a) Strain C42 was cultivated on marine agar for 48 h
and then overlaid with dialysis membrane (molecular weight cutoff,
12,000 to 14,000). Soft agar inoculated with V. harveyi BB120 was
poured over the surface of the plate and incubated for 16 h at 28°C.
The picture is a light image showing decreased bioluminescence sur-
rounding a colony of isolate C42. (b) Light image of a disc diffusion
assay of the bacterial (left) and synthetic (right) metabolite 2. The
growth of V. harveyi was not visibly inhibited surrounding the C42
colony or the discs.
FIG. 3. Concentration-dependent inhibition of bioluminescence by
planktonic V. harveyi. V. harveyi strain BB120 regulates biolumines-
cence via AHL-mediated quorum sensing. Serial dilutions of metabo-
lite 2 were added to microtiter plate wells containing dilutions of V.
harveyi BB120 and incubated for 4 h. Relative fluorescence units
(RLU) were normalized for growth (OD600). No bacterial growth
inhibition, noted by optical density values 14 h after the end point, was
observed over the concentration range of the assay (dark line).
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AHL signals, concentrations of agonist (OHHL) and antago-
nist can be manipulated to investigate agonist-antagonist rela-
tionships (27). Similar dose-response, competition methods
have been used to investigate the potential mechanisms of
action of synthetic quorum sensing antagonists (20, 34). Me-
tabolite 1 had no notable activity in this assay, while metabolite
2 displayed concentration-dependent inhibition of GFP (Fig.
4a, EC50  19 g/ml at 32 nM OHHL). No E. coli growth
inhibition was measured (OD450) at 200 g/ml of metabolite 2
after 14 h, the highest concentration tested. Next, compound 2
was tested in serial dilutions against rising concentrations of
OHHL (16 to 512 nM). Increased OHHL surmounted the
inhibitory effects of 2 (Fig. 4b), consistent with an agonist-
antagonist relationship. To better understand the nature of this
antagonism, the measured effects of OHHL and compound 2
were plotted against values predicted by pharmacodynamic
models for competitive and noncompetitive antagonism (Fig.
4c) (22). The mathematical model for competitive antagonism
(equation 1) provided an excellent correlation with the exper-
imentally observed responses, with an R2 value of 0.92 indicat-
ing that 92% of the variability in the effect can be explained
from the concentration of agonist and antagonist and by the
model used. This competitive antagonist model also yielded
good precision for Emax (122  6 g/ml) and EC50 (28  7
g/ml) values estimated as judged by low standard error val-
ues. In contrast, the model for noncompetitive antagonism
provided a much poorer fit (R2  0.77) and higher values of
standard error (Emax  74  22 g/ml and EC50  106  62
g/ml).
Enhanced antagonism effects of additional bacterial metab-
olites. Crude extracts from the Halobacillus cultures were more
active in disc diffusion assays than the isolated metabolites.
However, the bioassay-guided fractionation led only to phen-
ethylamides 1 and 2 as possessing the desired bioactivities.
Therefore, it was hypothesized that another compound(s)
might work in concert with the identified metabolites to aug-
ment the activity. During the silica gel chromatography step of
the bioassay-guided fractionation, the fourth fraction (80%
EtOAc in TMP) was composed almost entirely of metabolites
1 and 2. This material was retested in the V. harveyi BB120 disc
diffusion assay in combination with the other fractions (250
g/disc per fraction). It was determined that the second frac-
tion (40% EtOAc in TMP) significantly enhanced biolumines-
cence inhibition when assayed in combination (ZOI 75 mm).
Interestingly, this fraction exhibited no observable activity of
its own at 500 g/disc. 1H NMR spectra of this material sug-
gested that it was composed of lipophilic compounds possess-
ing long alkyl chains. Unfortunately, further chromatographic
separation of fraction 2 resulted in loss of the enhanced inhib-
itory effects.
DISCUSSION
Antagonism of quorum sensing has previously been ob-
served between closely related species of bacteria. Antagonist
activity arises from slight structural variations between similar
autoinducers. For example, quorum sensing inhibition has
been observed between subgroups of S. aureus isolates, with
structurally distinct autoinducing peptides from one subgroup
able to chemically antagonize the signaling systems of others
(21). Inhibition of quorum sensing also occurs between the
closely related species S. aureus and Staphylococcus epidermidis
(1). In gram-negative bacteria, AHL receptor proteins are ac-
tivated most efficiently by their native autoinducers. Small al-
FIG. 4. Antagonism of OHHL-mediated GFP production by E. coli
JB525. E. coli strain JB525 produces the LuxR of V. fischeri and makes
an unstable GFP in response to exogenously added AHL autoinducers.
(a) H. salinus metabolite 2 blocks GFP production in a concentration-
dependent manner. The graph shows assay results with OHHL sup-
plied at 32 nm. No growth inhibition of the bacterium was observed
over the concentration range of the assay (dark line) at 14 h. (b)
Surface plot showing GFP production (fluorescence) at various con-
centrations of antagonist (compound 2) and agonist (OHHL). The
inhibitory activity of compound 2 is surmounted by higher concentra-
tions of OHHL agonist, consistent with an antagonist-agonist relation-
ship. The concentration of compound 2 is micromolar and that of
OHHL is nanomolar before conversion to log scale. (c) Plot of mea-
sured versus predicted responses using the stated pharmacodynamic
model. Predicted responses were calculated using equations that
model competitive and noncompetitive antagonism. The solid line is
the line of unity. Response (fluorescence) is normalized to 100%.
Measured values correlate better with those predicted for competitive
antagonism (, R2  0.92) than with those predicted for noncompet-
itive antagonism (Œ, R2  0.76).
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terations in the AHL structure can disrupt proper signaling,
either diminishing or abolishing subsequent gene transcription.
To illustrate, decanoyl homoserine lactone, the native autoin-
ducer for Burkholderia pseudomallei (41), potently inhibits the
HHL quorum sensing system of C. violaceum (31).
Differing from the studies discussed above, here we observed
inhibition of quorum sensing phenotypes between distantly
related bacteria. The structures for the two bioactive metabo-
lites were previously identified from a limnic Bacillus species.
Neither molecule demonstrated toxicity when tested against a
panel of microalgae, bacteria, and fungi at concentrations up
to 200 g/ml (30). The quorum sensing-inhibitory properties of
these metabolites are reported here for the first time.
Pharmacodynamic modeling demonstrated that the experi-
mentally measured responses in the E. coli JB525 assay are
consistent with those predicted for competitive antagonism.
Competitive antagonists lack intrinsic efficacy but bind to the
same receptor site as does the native agonist. Like AHLs, the
H. salinus metabolites possess a ring system with a side chain
connected via an amide bond. In synthetic studies that have
targeted the creation of quorum sensing antagonists based on
AHL structural motifs, inhibitors have been designed with a
phenyl ring appended to either the end of the acyl chain or
replacing the lactone ring. For example, 4-phenylbutanoyl ho-
moserine lactone inhibits the binding of OHHL in E. coli
containing LuxR and also antagonizes LuxR in V. fischeri (12,
37). 3-Oxo-C12-(2-aminophenol) was found to inhibit GFP
production in a Pseudomonas aeruginosa strain constructed to
express GFP in its quorum sensing circuit (39), as well as TraR
in Agrobacterium tumefaciens (13). The phenethylamide me-
tabolites described here represent a new chemotype of quorum
sensing inhibitors from nature.
Lipophilic metabolites appear to work in concert with the
identified metabolites for maximum attenuation of quorum
sensing. This result is not entirely unexpected, since some
lipids can enhance the sensitivity of bacteria to antibiotics by
modifying cell permeability (23). Attempts to purify the activ-
ity-enhancing compounds were unsuccessful, suggesting that
several lipophilic molecules might be acting in concert to exert
this effect. Further investigation is under way to elucidate the
nature of this combination result. Nevertheless, the pure phen-
ethylamide metabolites demonstrated inhibition of quorum
sensing-regulated behaviors in an array of assays, and synthet-
ically prepared compounds reproduced these activities identi-
cally.
The ubiquitous marine bacterium V. harveyi was selected as
an assay strain since it could be cocultured with H. salinus on
seawater agar plates and has a well-studied quorum sensing
system. Chemical communication by V. harveyi is accomplished
via three parallel pathways that utilize the autoinducers HAI-1,
CAI-1, and AI-2. HAI-1 is 3-hydroxybutanoyl-L-homoserine
lactone and facilitates the species-specific AHL pathway (2).
CAI-1 has recently been established as (S)-3-hydroxytridecan-
4-one (16, 19) and may serve as an intergenus communication
molecule. AI-2 is a furanosyl borate diester that has been
proposed to play a role in interspecies communication (2). In
addition to bioluminescence (35, 40), these three parallel quo-
rum sensing systems regulate type III secretion (17), sid-
erophore and polysaccharide production (24), and metallopro-
tease production (32). Inhibition of the HAI-1 pathway by the
phenethylamide metabolites is consistent with a strong de-
crease in V. harveyi bioluminescence. Genetic knockouts of the
HAI-1 pathway lead to a 99.9% reduction in bioluminescence
(16).
Several eukaryotes, including plants and fungi, have been
shown to produce secondary metabolites that interfere with
quorum sensing pathways of gram-negative bacteria (29, 36,
38, 42). Cell signaling antagonists are proposed to have a
protective effect against pathogens and microbial fouling (14).
The H. salinus isolate studied here suggests that some gram-
positive bacteria have also developed this chemical skill, per-
haps as a mechanism to compete within microbial assemblages
in their natural environments. Prevention of coordinated bac-
terial behaviors such as swarming motility, antibiotic secretion,
and biofilm production could greatly impede the success of a
bacterial community in competing for space and other re-
sources. Indeed, quorum sensing antagonists have been pro-
posed as mechanistically novel antimicrobial drugs (18). Fur-
ther investigations are currently under way to survey the
prevalence of such nontoxic interactions in the marine envi-
ronment and also to better understand the ecological signifi-
cance of quorum sensing antagonism in bacterial competition.
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